Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 0.302% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1nnc(SCC(=O)NNC(=O)c2ccccc2)n1-c1ccccc1
b Cc1cc(=O)oc2cc(NC(=O)c3ccnn3C)ccc12
Answer: a. Cc1nnc(SCC(=O)NNC(=O)c2ccccc2)n1-c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(SCC(=O)NNC(=O)c2ccccc2)n1-c1ccccc1
Cc1nnc(SCC(=O)NNC(=O)c2ccccc2)n1-c1ccccc1
N'-[2-[(5-methyl-4-phenyl-1,2,4-triazol-3-yl)sulfanyl]acetyl]benzohydrazide